IDEXX Laboratories, a leading provider of veterinary diagnostics and software, reported strong third-quarter earnings, exceeding analysts’ expectations. However, the company’s stock price plummeted over 9% on concerns about slowing growth in the veterinary industry. The company’s revenue growth was driven by its Companion Animal and Water segments, but a continued decline in veterinary office visits is raising concerns about the near-term outlook. Despite the short-term challenges, analysts remain optimistic about IDEXX’s long-term growth prospects.